nodes	percent_of_prediction	percent_of_DWPC	metapath
Metocurine—CHRNA2—epilepsy syndrome	0.589	0.737	CbGaD
Metocurine—CHRM2—epilepsy syndrome	0.21	0.263	CbGaD
Metocurine—Tubocurarine—CHRNA2—epilepsy syndrome	0.00495	0.737	CrCbGaD
Metocurine—CHRNA1—tongue—epilepsy syndrome	0.00436	0.215	CbGeAlD
Metocurine—Tubocurarine—CHRM2—epilepsy syndrome	0.00177	0.263	CrCbGaD
Metocurine—CHRNA2—forebrain—epilepsy syndrome	0.00153	0.0755	CbGeAlD
Metocurine—CHRNA1—head—epilepsy syndrome	0.00106	0.0521	CbGeAlD
Metocurine—CHRNB1—medulla oblongata—epilepsy syndrome	0.00103	0.0508	CbGeAlD
Metocurine—CHRNB1—midbrain—epilepsy syndrome	0.000943	0.0464	CbGeAlD
Metocurine—CHRNB1—spinal cord—epilepsy syndrome	0.00092	0.0453	CbGeAlD
Metocurine—CHRM2—forebrain—epilepsy syndrome	0.000915	0.045	CbGeAlD
Metocurine—CHRNA2—head—epilepsy syndrome	0.000879	0.0432	CbGeAlD
Metocurine—CHRM2—telencephalon—epilepsy syndrome	0.000842	0.0414	CbGeAlD
Metocurine—CHRNA2—nervous system—epilepsy syndrome	0.000833	0.041	CbGeAlD
Metocurine—CHRNB1—head—epilepsy syndrome	0.000818	0.0402	CbGeAlD
Metocurine—CHRNA2—central nervous system—epilepsy syndrome	0.000802	0.0395	CbGeAlD
Metocurine—CHRNA2—cerebellum—epilepsy syndrome	0.000784	0.0386	CbGeAlD
Metocurine—CHRNA1—brain—epilepsy syndrome	0.000767	0.0378	CbGeAlD
Metocurine—CHRNB1—cerebellum—epilepsy syndrome	0.00073	0.0359	CbGeAlD
Metocurine—CHRNA2—brain—epilepsy syndrome	0.000637	0.0313	CbGeAlD
Metocurine—CHRNB1—brain—epilepsy syndrome	0.000593	0.0291	CbGeAlD
Metocurine—CHRM2—head—epilepsy syndrome	0.000524	0.0258	CbGeAlD
Metocurine—CHRM2—nervous system—epilepsy syndrome	0.000497	0.0244	CbGeAlD
Metocurine—CHRM2—central nervous system—epilepsy syndrome	0.000478	0.0235	CbGeAlD
Metocurine—CHRM2—brain—epilepsy syndrome	0.00038	0.0187	CbGeAlD
Metocurine—CHRM2—GPCR ligand binding—CHRM3—epilepsy syndrome	3.72e-05	0.000214	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—GRM5—epilepsy syndrome	3.72e-05	0.000214	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—BDKRB2—epilepsy syndrome	3.72e-05	0.000214	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—ACKR4—epilepsy syndrome	3.68e-05	0.000212	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—SSTR4—epilepsy syndrome	3.66e-05	0.000211	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—SSTR5—epilepsy syndrome	3.66e-05	0.000211	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—CNR1—epilepsy syndrome	3.65e-05	0.00021	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—CX3CR1—epilepsy syndrome	3.57e-05	0.000205	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR7—epilepsy syndrome	3.56e-05	0.000205	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—CCR10—epilepsy syndrome	3.51e-05	0.000202	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—BDKRB1—epilepsy syndrome	3.5e-05	0.000201	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—CX3CL1—epilepsy syndrome	3.5e-05	0.000201	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—GABBR1—epilepsy syndrome	3.4e-05	0.000196	CbGpPWpGaD
Metocurine—CHRM2—Calcium Regulation in the Cardiac Cell—PRKCB—epilepsy syndrome	3.39e-05	0.000195	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—SST—epilepsy syndrome	3.39e-05	0.000195	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR2—epilepsy syndrome	3.39e-05	0.000195	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—SSTR5—epilepsy syndrome	3.33e-05	0.000191	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—SSTR4—epilepsy syndrome	3.33e-05	0.000191	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—epilepsy syndrome	3.32e-05	0.000191	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—HRH3—epilepsy syndrome	3.26e-05	0.000188	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—OPRM1—epilepsy syndrome	3.21e-05	0.000185	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CCR10—epilepsy syndrome	3.19e-05	0.000183	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL12—epilepsy syndrome	3.19e-05	0.000183	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—BDKRB2—epilepsy syndrome	3.19e-05	0.000183	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CNR1—epilepsy syndrome	3.13e-05	0.00018	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—GRM2—epilepsy syndrome	3.07e-05	0.000177	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR7—epilepsy syndrome	3.05e-05	0.000175	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—CCR3—epilepsy syndrome	3.03e-05	0.000175	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—NPY—epilepsy syndrome	2.96e-05	0.00017	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—CRH—epilepsy syndrome	2.85e-05	0.000164	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—OXT—epilepsy syndrome	2.85e-05	0.000164	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—CCL3—epilepsy syndrome	2.85e-05	0.000164	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—CXCL2—epilepsy syndrome	2.85e-05	0.000164	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GRM2—epilepsy syndrome	2.79e-05	0.00016	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—SSTR3—epilepsy syndrome	2.78e-05	0.00016	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—CCR5—epilepsy syndrome	2.75e-05	0.000158	CbGpPWpGaD
Metocurine—CHRM2—Regulation of Actin Cytoskeleton—FGF2—epilepsy syndrome	2.73e-05	0.000157	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—CCR9—epilepsy syndrome	2.66e-05	0.000153	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	2.66e-05	0.000153	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—NPY2R—epilepsy syndrome	2.66e-05	0.000153	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—SSTR1—epilepsy syndrome	2.66e-05	0.000153	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—CCR8—epilepsy syndrome	2.66e-05	0.000153	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—GRM4—epilepsy syndrome	2.61e-05	0.00015	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—GRM3—epilepsy syndrome	2.61e-05	0.00015	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—CCR2—epilepsy syndrome	2.58e-05	0.000148	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—SST—epilepsy syndrome	2.58e-05	0.000148	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	2.57e-05	0.000148	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—SSTR2—epilepsy syndrome	2.56e-05	0.000147	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—AGT—epilepsy syndrome	2.55e-05	0.000147	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—epilepsy syndrome	2.55e-05	0.000147	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—ADRA2A—epilepsy syndrome	2.52e-05	0.000145	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—SSTR3—epilepsy syndrome	2.52e-05	0.000145	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—epilepsy syndrome	2.49e-05	0.000143	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PRDM4—epilepsy syndrome	2.49e-05	0.000143	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PRICKLE1—epilepsy syndrome	2.49e-05	0.000143	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—GRM8—epilepsy syndrome	2.47e-05	0.000142	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—BDKRB2—epilepsy syndrome	2.43e-05	0.00014	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—CXCL12—epilepsy syndrome	2.43e-05	0.00014	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—ARHGEF9—epilepsy syndrome	2.42e-05	0.000139	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CCR9—epilepsy syndrome	2.42e-05	0.000139	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—NPY2R—epilepsy syndrome	2.42e-05	0.000139	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CCR8—epilepsy syndrome	2.42e-05	0.000139	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—SSTR1—epilepsy syndrome	2.42e-05	0.000139	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—CNR1—epilepsy syndrome	2.38e-05	0.000137	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GRM4—epilepsy syndrome	2.37e-05	0.000136	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GRM3—epilepsy syndrome	2.37e-05	0.000136	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—OPRD1—epilepsy syndrome	2.36e-05	0.000136	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—SSTR2—epilepsy syndrome	2.33e-05	0.000134	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—HTR7—epilepsy syndrome	2.32e-05	0.000134	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—PDYN—epilepsy syndrome	2.26e-05	0.00013	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—CCR7—epilepsy syndrome	2.26e-05	0.00013	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—GRM1—epilepsy syndrome	2.26e-05	0.00013	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—CHRM1—epilepsy syndrome	2.26e-05	0.00013	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GRM8—epilepsy syndrome	2.25e-05	0.000129	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	2.21e-05	0.000127	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	2.21e-05	0.000127	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	2.18e-05	0.000126	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—ACKR4—epilepsy syndrome	2.17e-05	0.000125	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—POMC—epilepsy syndrome	2.15e-05	0.000123	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GNAO1—epilepsy syndrome	2.14e-05	0.000123	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—OPRD1—epilepsy syndrome	2.14e-05	0.000123	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	2.14e-05	0.000123	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	2.14e-05	0.000123	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—GAL—epilepsy syndrome	2.13e-05	0.000122	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—CHRM3—epilepsy syndrome	2.1e-05	0.000121	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—GRM5—epilepsy syndrome	2.1e-05	0.000121	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CHRM1—epilepsy syndrome	2.05e-05	0.000118	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GRM1—epilepsy syndrome	2.05e-05	0.000118	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CCR7—epilepsy syndrome	2.05e-05	0.000118	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—PDYN—epilepsy syndrome	2.05e-05	0.000118	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	2.03e-05	0.000117	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—BDKRB1—epilepsy syndrome	1.98e-05	0.000114	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—SSTR5—epilepsy syndrome	1.96e-05	0.000113	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—SSTR4—epilepsy syndrome	1.96e-05	0.000113	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—AVP—epilepsy syndrome	1.96e-05	0.000112	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GAL—epilepsy syndrome	1.93e-05	0.000111	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—GABBR1—epilepsy syndrome	1.92e-05	0.000111	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GRM5—epilepsy syndrome	1.91e-05	0.00011	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CHRM3—epilepsy syndrome	1.91e-05	0.00011	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CCR10—epilepsy syndrome	1.88e-05	0.000108	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	1.87e-05	0.000108	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—HRH3—epilepsy syndrome	1.84e-05	0.000106	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CX3CR1—epilepsy syndrome	1.83e-05	0.000105	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—OPRM1—epilepsy syndrome	1.82e-05	0.000104	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—BDKRB1—epilepsy syndrome	1.8e-05	0.000103	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CX3CL1—epilepsy syndrome	1.8e-05	0.000103	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GABBR1—epilepsy syndrome	1.75e-05	0.000101	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—CCR3—epilepsy syndrome	1.71e-05	9.86e-05	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	1.71e-05	9.82e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—HRH3—epilepsy syndrome	1.67e-05	9.64e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—NPY—epilepsy syndrome	1.67e-05	9.61e-05	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	1.67e-05	9.6e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—CCR5—epilepsy syndrome	1.66e-05	9.56e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—OPRM1—epilepsy syndrome	1.65e-05	9.49e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GRM2—epilepsy syndrome	1.65e-05	9.47e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—HTR2A—epilepsy syndrome	1.63e-05	9.36e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—CRH—epilepsy syndrome	1.61e-05	9.28e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—CXCL2—epilepsy syndrome	1.61e-05	9.28e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—OXT—epilepsy syndrome	1.61e-05	9.28e-05	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	1.6e-05	9.23e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CCR3—epilepsy syndrome	1.56e-05	8.96e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—AGT—epilepsy syndrome	1.54e-05	8.88e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—NPY—epilepsy syndrome	1.52e-05	8.73e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—SSTR3—epilepsy syndrome	1.49e-05	8.57e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CRH—epilepsy syndrome	1.46e-05	8.42e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CXCL2—epilepsy syndrome	1.46e-05	8.42e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—OXT—epilepsy syndrome	1.46e-05	8.42e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CCL3—epilepsy syndrome	1.46e-05	8.42e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—CCR2—epilepsy syndrome	1.46e-05	8.39e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—SST—epilepsy syndrome	1.46e-05	8.39e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—ST3GAL3—epilepsy syndrome	1.46e-05	8.38e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—SSTR1—epilepsy syndrome	1.43e-05	8.21e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—NPY2R—epilepsy syndrome	1.43e-05	8.21e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—ARHGEF9—epilepsy syndrome	1.43e-05	8.21e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CCR8—epilepsy syndrome	1.43e-05	8.21e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CCR9—epilepsy syndrome	1.43e-05	8.21e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—ADRA2A—epilepsy syndrome	1.43e-05	8.21e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GRM3—epilepsy syndrome	1.4e-05	8.05e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GRM4—epilepsy syndrome	1.4e-05	8.05e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—DUSP4—epilepsy syndrome	1.37e-05	7.91e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—SSTR2—epilepsy syndrome	1.37e-05	7.91e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—BDKRB2—epilepsy syndrome	1.37e-05	7.89e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—CXCL12—epilepsy syndrome	1.37e-05	7.89e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—CNR1—epilepsy syndrome	1.35e-05	7.74e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—PLCB1—epilepsy syndrome	1.34e-05	7.71e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GRM8—epilepsy syndrome	1.33e-05	7.63e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PGF—epilepsy syndrome	1.33e-05	7.63e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CCR2—epilepsy syndrome	1.32e-05	7.62e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—SST—epilepsy syndrome	1.32e-05	7.62e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—HTR7—epilepsy syndrome	1.31e-05	7.55e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—POMC—epilepsy syndrome	1.3e-05	7.48e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—ADRA2A—epilepsy syndrome	1.3e-05	7.45e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—CCL2—epilepsy syndrome	1.27e-05	7.31e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GNAO1—epilepsy syndrome	1.27e-05	7.28e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—OPRD1—epilepsy syndrome	1.27e-05	7.28e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—AKT3—epilepsy syndrome	1.25e-05	7.2e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CXCL12—epilepsy syndrome	1.24e-05	7.16e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—BDKRB2—epilepsy syndrome	1.24e-05	7.16e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CNR1—epilepsy syndrome	1.22e-05	7.03e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—PLCB1—epilepsy syndrome	1.22e-05	7e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CHRM1—epilepsy syndrome	1.21e-05	6.98e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PDYN—epilepsy syndrome	1.21e-05	6.98e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CCR7—epilepsy syndrome	1.21e-05	6.98e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GRM1—epilepsy syndrome	1.21e-05	6.98e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—HTR7—epilepsy syndrome	1.19e-05	6.86e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—HBEGF—epilepsy syndrome	1.16e-05	6.66e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—CDC42—epilepsy syndrome	1.14e-05	6.57e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GAL—epilepsy syndrome	1.14e-05	6.57e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GFAP—epilepsy syndrome	1.14e-05	6.57e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—AKT3—epilepsy syndrome	1.14e-05	6.54e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GRM5—epilepsy syndrome	1.13e-05	6.49e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CASP2—epilepsy syndrome	1.13e-05	6.49e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CHRM3—epilepsy syndrome	1.13e-05	6.49e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—AVP—epilepsy syndrome	1.1e-05	6.36e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CX3CR1—epilepsy syndrome	1.08e-05	6.22e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—BDKRB1—epilepsy syndrome	1.06e-05	6.1e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CX3CL1—epilepsy syndrome	1.06e-05	6.1e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CDC42—epilepsy syndrome	1.04e-05	5.96e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GABBR1—epilepsy syndrome	1.03e-05	5.94e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—AVP—epilepsy syndrome	1e-05	5.77e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—HRH3—epilepsy syndrome	9.89e-06	5.69e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—OPRM1—epilepsy syndrome	9.74e-06	5.6e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—CCR5—epilepsy syndrome	9.39e-06	5.41e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CCR3—epilepsy syndrome	9.2e-06	5.29e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—HTR2A—epilepsy syndrome	9.19e-06	5.29e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—NPY—epilepsy syndrome	8.96e-06	5.16e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—ATP2A2—epilepsy syndrome	8.96e-06	5.16e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—AGT—epilepsy syndrome	8.72e-06	5.02e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	8.65e-06	4.98e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	8.65e-06	4.98e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	8.65e-06	4.98e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	8.65e-06	4.98e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	8.65e-06	4.98e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	8.53e-06	4.91e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	8.35e-06	4.8e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	8.06e-06	4.64e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	8.04e-06	4.63e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	8.04e-06	4.63e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	7.92e-06	4.56e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—SST—epilepsy syndrome	7.82e-06	4.5e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	7.82e-06	4.5e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	7.82e-06	4.5e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	7.75e-06	4.46e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	7.65e-06	4.4e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	7.62e-06	4.39e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	7.35e-06	4.23e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	7.35e-06	4.23e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	7.34e-06	4.22e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	7.32e-06	4.21e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	7.29e-06	4.19e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	7.22e-06	4.15e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	7.22e-06	4.15e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	7.19e-06	4.14e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	7.04e-06	4.05e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	6.84e-06	3.93e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	6.71e-06	3.86e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	6.67e-06	3.84e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	6.55e-06	3.77e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	6.52e-06	3.75e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	6.2e-06	3.57e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	6.14e-06	3.53e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	6.12e-06	3.52e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	5.93e-06	3.41e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	5.6e-06	3.22e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	5.45e-06	3.14e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	5.43e-06	3.12e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	5.42e-06	3.12e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	5.24e-06	3.01e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	5.18e-06	2.98e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	5.04e-06	2.9e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	4.93e-06	2.84e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	4.69e-06	2.7e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	4.68e-06	2.69e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	4.59e-06	2.64e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	4.49e-06	2.58e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	4.32e-06	2.49e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	4.31e-06	2.48e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	3.94e-06	2.27e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	3.85e-06	2.22e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	3.48e-06	2e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	3.23e-06	1.86e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	3.17e-06	1.82e-05	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.94e-06	1.69e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	2.92e-06	1.68e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	2.83e-06	1.63e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	2.76e-06	1.59e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	2.67e-06	1.54e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	2.54e-06	1.46e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	2.47e-06	1.42e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.58e-06	9.08e-06	CbGpPWpGaD
